BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27213811)

  • 1. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.
    Hu Q; Gao F; Tian W; Ruteshouser EC; Wang Y; Lazar A; Stewart J; Strong LC; Behringer RR; Huff V
    J Clin Invest; 2011 Jan; 121(1):174-83. PubMed ID: 21123950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
    Mittal K; Cooper GW; Lee BP; Su Y; Skinner KT; Shim J; Jonus HC; Kim WJ; Doshi M; Almanza D; Kynnap BD; Christie AL; Yang X; Cowley GS; Leeper BA; Morton CL; Dwivedi B; Lawrence T; Rupji M; Keskula P; Meyer S; Clinton CM; Bhasin M; Crompton BD; Tseng YY; Boehm JS; Ligon KL; Root DE; Murphy AJ; Weinstock DM; Gokhale PC; Spangle JM; Rivera MN; Mullen EA; Stegmaier K; Goldsmith KC; Hahn WC; Hong AL
    Commun Biol; 2024 Apr; 7(1):426. PubMed ID: 38589567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture.
    Wojcik HM; Lovvorn HN; Hollingshead M; Pierce J; Stotler H; Murphy AJ; Borgel S; Phelps HM; Correa H; Perantoni AO
    Front Oncol; 2023; 13():1091274. PubMed ID: 37007076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.
    Royer-Pokora B; Wruck W; Adjaye J; Beier M
    PLoS One; 2023; 18(1):e0270380. PubMed ID: 36689432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different
    Royer-Pokora B; Busch MA; Tenbusch S; Schmidt M; Beier M; Woods AD; Thiele H; Mora J
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33379206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal Heterogeneity of the G-401 Rhabdoid Tumor Cell Line: Unusual Partial 7p Trisomy.
    Fasler-Kan E; Aliu N; Haecker FM; Maltsev N; Ruggiero S; Cholewa D; Bartenstein A; Milošević M; Berger SM
    Front Med (Lausanne); 2019; 6():187. PubMed ID: 31544104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of conditionally immortalized cells for renal replacement therapy.
    Mihajlovic M; Hariri S; Westphal KCG; Janssen MJ; Oost MJ; Bongiovanni L; van den Heuvel LP; de Bruin A; Hilbrands LB; Masereeuw R
    Oncotarget; 2019 Sep; 10(51):5332-5348. PubMed ID: 31523392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
    Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
    Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
    Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
    Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
    Brandt A; Löhers K; Beier M; Leube B; de Torres C; Mora J; Arora P; Jat PS; Royer-Pokora B
    PLoS One; 2016; 11(5):e0155561. PubMed ID: 27213811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stratification of Wilms tumor by genetic and epigenetic analysis.
    Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
    Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.